AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation allosteric small molecule integrin modulators to address major unmet medical needs of severe chronic autoimmunity. AlloCyte was founded by reputated drug developers, private investors and integrin experts of pharma-industrial, academic, business and clinical backgrounds. AlloCyte’s drug development programs are fueled by cutting-edge drug discovery, driven by scientific rigor and advanced by the resilience to take the route less travelled if this is where patient needs and data evidence guide.
Company Details
- Employees
- 1
- Address
- 4057 Basel
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- 4057 Basel
Allocyte Pharmaceuticals Ag Questions
Allocyte Pharmaceuticals Ag's website is http://www.allocyte-pharmaceuticals.com
Allocyte Pharmaceuticals Ag's LinkedIn profile is https://ch.linkedin.com/company/allocyte-pharmaceuticals-ag
Allocyte Pharmaceuticals Ag has
1 employees.
View email and phone details for 1
employees at Allocyte Pharmaceuticals Ag.
Allocyte Pharmaceuticals Ag's industry is
Biotechnology Research
Allocyte Pharmaceuticals Ag's top competitors are
Alpex Pharma Sa,
Advesya,
Strekin,
4xd Pharma Consulting,
Acino,
Acsana Ag,
Addex Therapeutics,
A. Menarini Gmbh,
Granite Bio,
Obexia Ag.
Allocyte Pharmaceuticals Ag's support email address is info@allocyte-pharma.com
Allocyte Pharmaceuticals Ag's categories are Biotechnology Research
